Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise

Parkinson’s Disease (PD) is a prevalent and complex age-related neurodegenerative condition for which there are no disease-modifying treatments currently available. The pathophysiological process underlying PD remains incompletely understood but increasing evidence points to multiple system dysfunct...

Full description

Bibliographic Details
Main Authors: Nijee S. Luthra, Demetra D. Christou, Angela Clow, Daniel M. Corcos
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnins.2023.1228444/full
_version_ 1827822282477666304
author Nijee S. Luthra
Demetra D. Christou
Angela Clow
Daniel M. Corcos
author_facet Nijee S. Luthra
Demetra D. Christou
Angela Clow
Daniel M. Corcos
author_sort Nijee S. Luthra
collection DOAJ
description Parkinson’s Disease (PD) is a prevalent and complex age-related neurodegenerative condition for which there are no disease-modifying treatments currently available. The pathophysiological process underlying PD remains incompletely understood but increasing evidence points to multiple system dysfunction. Interestingly, the past decade has produced evidence that exercise not only reduces signs and symptoms of PD but is also potentially neuroprotective. Characterizing the mechanistic pathways that are triggered by exercise and lead to positive outcomes will improve understanding of how to counter disease progression and symptomatology. In this review, we highlight how exercise regulates the neuroendocrine system, whose primary role is to respond to stress, maintain homeostasis and improve resilience to aging. We focus on a group of hormones – cortisol, melatonin, insulin, klotho, and vitamin D – that have been shown to associate with various non-motor symptoms of PD, such as mood, cognition, and sleep/circadian rhythm disorder. These hormones may represent important biomarkers to track in clinical trials evaluating effects of exercise in PD with the aim of providing evidence that patients can exert some behavioral-induced control over their disease.
first_indexed 2024-03-12T01:55:50Z
format Article
id doaj.art-12176350909449a69de222d3476df07c
institution Directory Open Access Journal
issn 1662-453X
language English
last_indexed 2024-03-12T01:55:50Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neuroscience
spelling doaj.art-12176350909449a69de222d3476df07c2023-09-08T05:42:57ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2023-09-011710.3389/fnins.2023.12284441228444Targeting neuroendocrine abnormalities in Parkinson’s disease with exerciseNijee S. Luthra0Demetra D. Christou1Angela Clow2Daniel M. Corcos3Department of Neurology, University of California, San Francisco, San Francisco, CA, United StatesDepartment of Applied Physiology and Kinesiology, College of Health and Human Performance, University of Florida, Gainesville, FL, United StatesDepartment of Psychology, School of Social Sciences, University of Westminster, London, United KingdomDepartment of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, McCormick School of Engineering, Northwestern University, Chicago, IL, United StatesParkinson’s Disease (PD) is a prevalent and complex age-related neurodegenerative condition for which there are no disease-modifying treatments currently available. The pathophysiological process underlying PD remains incompletely understood but increasing evidence points to multiple system dysfunction. Interestingly, the past decade has produced evidence that exercise not only reduces signs and symptoms of PD but is also potentially neuroprotective. Characterizing the mechanistic pathways that are triggered by exercise and lead to positive outcomes will improve understanding of how to counter disease progression and symptomatology. In this review, we highlight how exercise regulates the neuroendocrine system, whose primary role is to respond to stress, maintain homeostasis and improve resilience to aging. We focus on a group of hormones – cortisol, melatonin, insulin, klotho, and vitamin D – that have been shown to associate with various non-motor symptoms of PD, such as mood, cognition, and sleep/circadian rhythm disorder. These hormones may represent important biomarkers to track in clinical trials evaluating effects of exercise in PD with the aim of providing evidence that patients can exert some behavioral-induced control over their disease.https://www.frontiersin.org/articles/10.3389/fnins.2023.1228444/fullParkinson’s diseaseexerciseneuroendocrinebiomarkersneurohormone
spellingShingle Nijee S. Luthra
Demetra D. Christou
Angela Clow
Daniel M. Corcos
Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
Frontiers in Neuroscience
Parkinson’s disease
exercise
neuroendocrine
biomarkers
neurohormone
title Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
title_full Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
title_fullStr Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
title_full_unstemmed Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
title_short Targeting neuroendocrine abnormalities in Parkinson’s disease with exercise
title_sort targeting neuroendocrine abnormalities in parkinson s disease with exercise
topic Parkinson’s disease
exercise
neuroendocrine
biomarkers
neurohormone
url https://www.frontiersin.org/articles/10.3389/fnins.2023.1228444/full
work_keys_str_mv AT nijeesluthra targetingneuroendocrineabnormalitiesinparkinsonsdiseasewithexercise
AT demetradchristou targetingneuroendocrineabnormalitiesinparkinsonsdiseasewithexercise
AT angelaclow targetingneuroendocrineabnormalitiesinparkinsonsdiseasewithexercise
AT danielmcorcos targetingneuroendocrineabnormalitiesinparkinsonsdiseasewithexercise